Metagenomi Stock (NASDAQ: MGX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 104.86K |
Day Range | - - - |
52 Wk Range | 3.34 - 12.74 |
Market Cap | $186.95M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 0.4% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Metagenomi (NASDAQ:MGX) through any online brokerage.
Other companies in Metagenomi’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE) and Adverum Biotechnologies (NASDAQ:ADVM).
There is no analysis for Metagenomi.
Metagenomi has a consensus price target of $17.83.
The stock price for Metagenomi (NASDAQ: MGX) is $4.99 last updated July 15, 2024 at 4:10 PM EDT.
There are no upcoming dividends for Metagenomi.
Metagenomi’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Metagenomi.
Metagenomi is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.